224 related articles for article (PubMed ID: 34712607)
1. Clinical Efficacy and Safety of Proton and Carbon Ion Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis.
Li M; Li X; Yao L; Han X; Yan W; Liu Y; Fu Y; Wang Y; Huang M; Zhang Q; Wang X; Yang K
Front Oncol; 2021; 11():709530. PubMed ID: 34712607
[TBL] [Abstract][Full Text] [Related]
2. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies.
Jefferson T; Formoso G; Venturelli F; Vicentini M; Chiarolla E; Ballini L
Recenti Prog Med; 2019 Dec; 110(12):566-586. PubMed ID: 31909760
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy.
Jang JY; Kim K; Chen MF; Akimoto T; Wang MLC; Kim MJ; Kim K; Lee TH; Yoo GS; Park HC
Cancer Med; 2024 Feb; 13(3):e7023. PubMed ID: 38396380
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis.
Chen Y; Luo H; Liu R; Tan M; Wang Q; Wu X; Du T; Liu Z; Sun S; Zhang Q; Wang X
Radiat Oncol; 2023 May; 18(1):86. PubMed ID: 37217970
[TBL] [Abstract][Full Text] [Related]
5. Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study.
Li P; Hong Z; Li Y; Fu S; Zhang Q
Front Oncol; 2021; 11():808216. PubMed ID: 35223457
[TBL] [Abstract][Full Text] [Related]
6. Preliminary exploration of clinical factors affecting acute toxicity and quality of life after carbon ion therapy for prostate cancer.
Zhang Y; Li P; Yu Q; Wu S; Chen X; Zhang Q; Fu S
Radiat Oncol; 2019 Jun; 14(1):94. PubMed ID: 31164172
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
8. The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx.
Hu J; Hu W; Gao J; Yang J; Qiu X; Huang Q; Kong L; Lu JJ
Ann Transl Med; 2022 Nov; 10(22):1198. PubMed ID: 36544666
[TBL] [Abstract][Full Text] [Related]
9. Particle Beam Radiation Therapy for Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinuses.
Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
Front Oncol; 2020; 10():572493. PubMed ID: 33102230
[No Abstract] [Full Text] [Related]
10. Particle beam therapy for pelvic recurrence of colorectal cancer: a registry data analysis in Japan and a systematic review.
Murayama S; Yamada S; Hiroshima Y; Takiyama H; Taguchi H; Kimoto T; Anzai M; Hagiwara Y; Yasui K; Mori K; Ishihara S; Ueno H; Shimizu S; Aoyama H; Tsuji H; Sakurai H
J Radiat Res; 2023 Jun; 64(Supplement_1):i25-i33. PubMed ID: 37117038
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis.
Yun JE; Kim S; Park KY; Lee W
Yonsei Med J; 2024 Jun; 65(6):332-340. PubMed ID: 38804027
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and toxicity of postoperative proton versus carbon ion radiotherapy for head and neck cancers.
Huang Q; Hu J; Hu W; Gao J; Yang J; Qiu X; Lu JJ; Kong L
Ann Transl Med; 2022 Nov; 10(22):1197. PubMed ID: 36544652
[TBL] [Abstract][Full Text] [Related]
13. Health Technology Assessment of Carbon-ion Beam Radiotherapy: A Systematic Review of Clinical Effectiveness and Safety for 54 Oncological Indications in 12 Tumour Regions.
Goetz G; Mitic M; Mittermayr T; Wild C
Anticancer Res; 2019 Apr; 39(4):1635-1650. PubMed ID: 30952702
[TBL] [Abstract][Full Text] [Related]
14. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.
Lawrie TA; Green JT; Beresford M; Wedlake L; Burden S; Davidson SE; Lal S; Henson CC; Andreyev HJN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012529. PubMed ID: 29360138
[TBL] [Abstract][Full Text] [Related]
17. Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.
Mishra MV; Khairnar R; Bentzen SM; Larson G; Tsai H; Sinesi C; Vargas C; Laramore G; Rossi C; Rosen L; Zhu M; Hartsell W
Clin Transl Radiat Oncol; 2019 Nov; 19():80-86. PubMed ID: 31650043
[TBL] [Abstract][Full Text] [Related]
18. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N
Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899
[TBL] [Abstract][Full Text] [Related]
19. Landscape of Carbon Ion Radiotherapy in Prostate Cancer: Clinical Application and Translational Research.
Chen X; Yu Q; Li P; Fu S
Front Oncol; 2021; 11():760752. PubMed ID: 34804961
[TBL] [Abstract][Full Text] [Related]
20. Five-year clinical outcomes of scanning carbon-ion radiotherapy for prostate cancer.
Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
PLoS One; 2024; 19(3):e0290617. PubMed ID: 38457424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
